A Holistic Approach to Evaluate the Cost-Effectiveness of Pembrolizumab with Multiple Indications- A Norway-Based Example
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.030
https://www.valueinhealthjournal.com/article/S1098-3015(18)30330-9/fulltext
Section Title :
Section Order :
1278
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30330-9&doi=10.1016/j.jval.2018.04.030